An Infection-Responsive Approach To Reduce Bacterial Adhesion in Urinary Biomaterials

Mol Pharm. 2016 Aug 1;13(8):2817-22. doi: 10.1021/acs.molpharmaceut.6b00402. Epub 2016 Jun 30.

Abstract

Infection is an inevitable consequence of chronic urinary catheterization with associated problems of recurrent catheter encrustation and blockage experienced by approximately 50% of all long-term catheterized patients. In this work, we have exploited, for the first time, the reported pathogen-induced elevation of urine pH as a trigger for "intelligent" antimicrobial release from novel hydrogel drug delivery systems of 2-hydroxyethyl methacrylate and vinyl-functionalized nalidixic acid derivatives, developed as candidate infection-resistant urinary catheter coatings. Demonstrating up to 20-fold faster rates of drug release at pH 10, representing infected urine pH, than at pH 7 and achieving reductions of up to 96.5% in in vitro bacterial adherence, our paradigm of pH-responsive drug delivery, which requires no external manipulation, therefore represents a promising development toward the prevention of catheter-associated urinary tract infections in vivo.

Keywords: drug conjugate copolymer; ester hydrolysis; pH-responsive; urinary catheter infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology
  • Bacterial Adhesion / drug effects*
  • Biocompatible Materials / chemistry*
  • Biocompatible Materials / pharmacology
  • Biofilms / drug effects
  • Catheter-Related Infections / prevention & control
  • Methacrylates / chemistry*
  • Nalidixic Acid / chemistry
  • Nalidixic Acid / pharmacology
  • Urinary Tract Infections / prevention & control

Substances

  • Anti-Infective Agents
  • Biocompatible Materials
  • Methacrylates
  • Nalidixic Acid
  • hydroxyethyl methacrylate